Ye Weimin, Held Maria, Enroth Helena, Kraaz Wolfgang, Engstrand Lars, Nyrén Olof
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Scand J Gastroenterol. 2005 Mar;40(3):312-8. doi: 10.1080/00365520510011542.
Serological evidence of antibodies to cytotoxin-associated gene A (CagA) antigens may exist without concomitant Helicobacter pylori IgG enzyme linked immunosorbent assay (ELISA) seropositivity. In a recent case-control study, this serological pattern was strongly linked to stomach cancer, and it was hypothesized to represent "burned-out" CagA-positive infections. The aim of this analysis was to test this hypothesis.
We used data from a Swedish endoscopy clinic-based case-control study with 64 gastric cancer cases and 281 age-matched and gender-matched non-cancer patients who had other gastric diseases or normal endoscopy. HM-CAP ELISA and Helicoblot 2.0 immunoblot results were compared with culture and histology.
Overall, 86 out of 345 (25%) subjects were CagA seropositive but ELISA seronegative. This proportion was similar among cancer and non-cancer patients. Current H. pylori infection could be verified by culture or histology in only 15% of these patients. Forty-three percent of subjects with this isolated CagA seropositivity had histological evidence of corpus and/or antral atrophy. This was higher than in those who were negative in both tests (15%), but lower than among those seropositive for both tests (53%). The percentage of isolated CagA-seropositive patients who had atrophy was similar among those with or without evidence of current infection.
Although false-positive tests for CagA, or false-negative ELISA tests, may explain the serologic pattern in some of the subjects with isolated CagA seropositivity, healed infections are estimated to account for the majority. Unless the histology is often restituted after spontaneous disappearance of the infection, atrophy does not appear to be a mandatory intermediate step leading to this serology.
细胞毒素相关基因A(CagA)抗原抗体的血清学证据可能在幽门螺杆菌IgG酶联免疫吸附测定(ELISA)血清学呈阳性的情况下单独存在。在最近一项病例对照研究中,这种血清学模式与胃癌密切相关,据推测这代表了“已治愈的”CagA阳性感染。本分析的目的是验证这一假设。
我们使用了瑞典一家内镜诊所的病例对照研究数据,该研究纳入了64例胃癌患者以及281例年龄和性别匹配的非癌症患者,这些非癌症患者患有其他胃部疾病或内镜检查正常。将HM-CAP ELISA和Helicoblot 2.0免疫印迹结果与培养和组织学结果进行比较。
总体而言,345名受试者中有86名(25%)CagA血清学呈阳性但ELISA血清学呈阴性。癌症患者和非癌症患者中的这一比例相似。在这些患者中,仅15%可通过培养或组织学证实存在当前幽门螺杆菌感染。43%的单纯CagA血清学呈阳性的受试者有胃体和/或胃窦萎缩的组织学证据。这一比例高于两项检测均为阴性的受试者(15%),但低于两项检测均为阳性的受试者(53%)。有或无当前感染证据的单纯CagA血清学呈阳性患者中出现萎缩的比例相似。
虽然CagA检测假阳性或ELISA检测假阴性可能解释部分单纯CagA血清学呈阳性受试者的血清学模式,但据估计已治愈的感染占大多数。除非感染自发消失后组织学经常恢复,否则萎缩似乎并非导致这种血清学结果的必经中间步骤。